Incomplete Item 5.02 Disclosure Ending Mid-Sentence (new) — Filing appears truncated with no substantive information about officer or director changes, suggesting potential filing error or missing material disclosure.

NASDAQ: TVTX Travere Therapeutics, Inc. 8-K

Travere files incomplete 8-K with truncated officer disclosure; stockholders approve 3M share equity plan increase

Filed May 21, 2026 · Period ending May 19, 2026 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TVTX commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 4:12 PM